14-day Premium Trial Subscription Sign Up For FreeGet Free

When Should You SELL Your Stocks? Click to watch.

$1.92 (-3.52%)

Volume: 90.122k

Closed: May 20, 2022

Hollow Logo Score: -4.305

Avinger Stock Forecast

BUY SELL NASDAQ:AVGR
$1.92 (-3.52%)

Volume: 90.122k

Closed: May 20, 2022

Score Hollow Logo -4.305

Avinger Company Profile

400 Chesapeake Drive

Redwood City CA 94063

650-241-7900

www.avinger.com

Industry: Medical Devices

Sector: Healthcare

Avinger

Description

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. The company develops lumivascular platform, which integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products include the Lightbox imaging console and Ocelot family of catheters, which are designed to penetrate total arterial blockages, known as chronic total occlusions (CTOs). The company is also developing Pantheris, an image-guided atherectomy device, which is designed to precisely remove arterial plaque in PAD patients. In addition, its first-generation CTO-crossing catheters, Wildcat and Kittycat 2, employ a proprietary design that uses a rotational spinning technique, allowing the physician to switch between a passive and active mode when navigating across a CTO. The company sells and markets its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE